Search Results for "Types Of Responders Of Hapatitis B Vaccine"

18:26 EST 22nd December 2014 | BioPortfolio

Original Source: Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Hepatitis B is a vaccine preventable infection which can be transmitted through occupational exposure. Approximately 15% of patients will not respond to an initial series of vaccination. Of those re-vaccinated approximately fifty percent will respond. On the basis of poor response to a third series, repeat vaccination is not recommended and non-responders are considered vulnerable to infection. Cardell studied the use of double dose combination hepatitis A and B vaccine (Tw...

Matching Channels

Streptococcal streptococcus pneumoniae vaccine

Pneumococcal disease is a leading cause of serious illness in children and adults throughout the world. The disease is caused by a common bacterium, Streptococcus pneumoniae, or pneumococcus, a gram-p...

Types

Types of stents

HPV vaccine

Types of cognitive error

Matching News

[Articles] Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

In women older than 25 years, the HPV 16/18 vaccine is efficacious against infections and cervical abnormalities associated with the vaccine types, as well as infections with the non-vaccine HPV types...

FDA approves Merck's HPV vaccine GARDASIL9

Merck, known as MSD outside the United States and Canada, announced that the US Food and Drug Administration (FDA) approved GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merck’s 9-...

HPV vaccine reduces prevalence of targeted and non-targeted HPV types

A human papillomavirus (HPV) vaccine used in Australia has reduced the prevalence of vaccine-targeted and non-targeted HPV types, researchers have found.

[Comment] Postlicensure monitoring of HPV vaccination programmes

In The Lancet Infectious Diseases, Sepehr Tabrizi and colleagues report data from a repeat cross-sectional study of vaccine-eligible women attending family planning clinics before and after quadrivale...

[Articles] Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

6 years after the initiation of the Australian HPV vaccination programme, we have detected a substantial fall in vaccine-targeted HPV genotypes in vaccinated women; a lower prevalence of vaccine-targe...

Rarer flu types 'could help with vaccine', say researchers

Rarer forms of flu may be the key to producing a vaccine that protects against many different strains, US scientists believe.

New vaccine against HPV infections imminent

Nine sub-types of the human papillomavirus are responsible for 85 per cent of pre-cancerous cells of the cervix. A new vaccine being tested at the University Department of Gynaecology at the MedUni Vi...

FDA Approval of Nonavalent HPV Vaccine Adds New Tool to Eradicate Cervical Cancer

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to t...

Matching PubMed Articles

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006.

A vaccine is available to prevent human papillomavirus (HPV) 6, 11, 16 and 18; in the prevaccine era, seropositivity to vaccine types is a measure of natural exposure.

Development of Neutralizing Monoclonal Antibodies for Oncogenic HPV Types 31, 33, 45, 52, and 58.

Human Papillomavirus (HPV) is the etiological agent for all cervical cancers, a significant number of other anogenital cancers, and a growing number of head-and-neck cancers. Two licensed vaccines off...

Differential Blood and Mucosal Immune Responses against an HIV-1 Vaccine Administered via Inguinal or Deltoid Injection.

Mucosal immunity is central to sexual transmission and overall pathogenesis of HIV-1 infection, but the ability of vaccines to induce immune responses in mucosal tissue compartments is poorly defined....

Personalized One-to-One Intervention in Agitated Individuals With Dementia: Responders versus Non-Responders.

The aim of the current study was to explore why some individuals with dementia and agitated behavior showed limited response to a personalized intervention. Ten consistently agitated individuals (i.e....

In-vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: implications for post-vaccine surveillance studies.

In populations where the prevalence of vaccine-targeted HPV types has been reduced significantly due to widespread vaccination of the target population, the sensitivity of some consensus-PCR-based ass...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement